MoneyWorks4Me

A decrease in the sales to Rs. 11603.30 millions was observed for the quarter ended June 2022. The sales stood at Rs. 12696.90 millions during the similar quarter previous year.Profit after Tax for the quarter ended June 2022 saw a decline of -62.40% from Rs. 1926.90 millions to Rs. 724.60  millions.Operating Profit reported a sharp decline to 1272.50 millions from 2787.10 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 11603.30 12696.90 -8.61 11603.30 12696.90 -8.61 49966.00 50514.40 -1.09
Other Income 6.20 41.60 -85.10 6.20 41.60 -85.10 499.80 835.20 -40.16
PBIDT 1272.50 2787.10 -54.34 1272.50 2787.10 -54.34 11044.30 15819.70 -30.19
Interest 87.00 20.30 328.57 87.00 20.30 328.57 166.70 127.70 30.54
PBDT 1185.50 2766.80 -57.15 1185.50 2766.80 -57.15 10877.60 15692.00 -30.68
Depreciation 460.90 434.90 5.98 460.90 434.90 5.98 1793.10 1526.00 17.50
PBT 724.60 2331.90 -68.93 724.60 2331.90 -68.93 9084.50 14166.00 -35.87
TAX 0.00 405.00 0.00 0.00 405.00 0.00 1144.50 2412.10 -52.55
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 724.60 1926.90 -62.40 724.60 1926.90 -62.40 7940.00 11753.90 -32.45
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 10.97 21.95 -50.04 10.97 21.95 -50.04 22.10 31.32 -29.42
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..